Skip to content

Teaching Physics to AI: How Aqemia Wants To Revolutionize Drug Discovery

Aqemia's Novel Approach to Drug Discovery Attracts €30M in New Funding

Aqemia co-founders: Emmanuelle Martiano-Rolland (COO) & Maximilien Levesque (CEO)

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest

Alan Goes All-In on AI
AI

Alan Goes All-In on AI

Six months after announcing a Series F funding round of €173 million at a €4 billion valuation, the French insurtech is accelerating its embrace of AI to transform its operations and products.

Members Public